The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2, open-label, randomized study of livmoniplimab in combination with budigalimab versus chemotherapy in patients with metastatic urothelial carcinoma.
 
Terence Friedlander
Honoraria - Abbvie; Astellas Pharma; EMD Serono; Merck
Consulting or Advisory Role - AADi; Astellas Pharma; Atkis; Bicycle Therapeutics; Bristol-Myers Squibb/Medarex; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer
Research Funding - Bicycle Therapeutics; Bristol-Myers Squibb (Inst); Neon Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bicycle Therapeutics; Merck
 
J. Thaddeus Beck
Research Funding - AbbVie (Inst); Amgen (Inst); AstraZeneca (Inst); DSi (Inst); Lilly (Inst); Nektar (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
 
Eli Rosenbaum
No Relationships to Disclose
 
Avivit Peer
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Medison; Merck Serono; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen-Cilag; Merck Serono; MSD Oncology; Novartis; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Pfizer
 
Shingo Hatakeyama
Honoraria - Astellas Pharma; AstraZeneca KK.; Bayer; Bristol-Myers Squibb; Janssen KK; Kaneka Corporation; Merck Biopharma Co.; Nipro Corporation; Ono Pharmaceuticals Co., Ltd.; Pfizer
 
Nadine Jahchan
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Cathy Zhou
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Cristiano Ferlini
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Sujata Jha
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Duyen Ngo
Employment - Abbvie; Alnylam (I); Bayer
Stock and Other Ownership Interests - Abbvie; Alnylam (I); Bayer
 
Matthew Galsky
Consulting or Advisory Role - Abbvie; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Curis; Daiichi Sankyo Europe GmbH; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792